Digital Genome Market Size, Share, Growth Analysis, By Type(Sequencing and Analyzer Instruments and Data Analysis and Management Tools.), By Application(Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research and Other Applications.), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2104 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 62 |Figures: 75

Digital Genome Market Insights

Digital Genome Market size was valued at USD 22.44 billion in 2022 and is poised to grow from USD 26.59 billion in 2023 to USD 151.4 billion by 2031, growing at a CAGR of 18.5% in the forecast period (2024-2031).

The global digital genome market has witnessed significant growth in recent years due to advancements in genomics and bioinformatics technologies. The market analysis of the global digital genome market reveals key insights into its size, growth potential, trends, and competitive landscape. One of the major drivers of the global digital genome market is the increasing adoption of next-generation sequencing (NGS) technologies. NGS has revolutionised the field of genomics by enabling rapid and cost-effective sequencing of DNA and RNA. The declining costs of NGS technologies have made genomic sequencing more accessible, leading to a surge in genomic data generation.

US Digital Genome Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 22.44 billion

Largest Segment

Sequencing and analyzer instruments

Fastest Growth

Sequencing and analyzer instruments

Growth Rate

18.5% CAGR

Global Digital Genome By Country ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Digital Genome Market Segmental Analysis

The global digital genome market is segmented by type, application, and region. Based on type, the market can be segmented into Sequencing and Analyzer Instruments and Data Analysis and Management Tools. Based on application, the market is segmented into Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research and Other Applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Digital Genome By Type

To get detailed analysis on other segments, Request For Free Sample Report

Digital Genome Market Regional Insights

North America emerges as the most dominant market for digital genome technologies. The dominance of this region can be attributed to several factors, including the presence of key market players, well-established healthcare infrastructure, and significant investments in genomics research. The US, in particular, is a major contributor to the North American market, with a high adoption rate of genomic technologies and strong government support in the form of funding and research initiatives.

Asia Pacific is expected to be the fastest-growing region in the global digital genome market. The rapid growth of the Asia Pacific region can be attributed to factors such as increasing awareness of genomic medicine, rising healthcare expenditure, and growing investments in genomics research and development. Countries like China, India, and Japan are witnessing significant advancements in genomic technologies and are actively promoting precision medicine initiatives, thus driving the market's growth in this region.

Global Digital Genome By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Digital Genome Market Dynamics

Digital Genome Market Drivers

Increasing Prevalence of Genetic Disorders

  • The global prevalence of genetic disorders is increasing, necessitating effective solutions for accurate diagnosis and early intervention. Digital genome technologies have emerged as valuable tools for precise genetic testing, screening, and diagnosis, enabling early detection, prevention, and treatment of genetic disorders.

Digital Genome Market Restraints

Ethical and Legal Considerations

  • The utilisation of genomic data raises important ethical and legal considerations that must be addressed. Issues such as data ownership, informed consent, and the potential for discrimination require careful deliberation. Striking a delicate balance between fostering innovation and addressing ethical concerns is crucial for ensuring the sustainable growth of the digital genome market.

Request Free Customization of this report to help us to meet your business objectives.

Digital Genome Market Competitive Landscape

The global digital genome market is characterised by intense competition among various players operating in this rapidly evolving sector. The market is witnessing significant growth, driven by advancements in genomic research, increasing adoption of precision medicine, and the growing need for personalised healthcare solutions. The competitive landscape of the market is shaped by factors such as technological innovations, strategic collaborations, research and development activities, and market expansion initiatives.

Digital Genome Market Top Player’s Company Profiles

  • Thermo Fisher Scientific (US)
  • Pacific Biosciences (US)
  • Oxford Nanopore Technologies (UK)
  • BGI Genomics (China)
  • PerkinElmer (US)
  • Qiagen (Netherlands)
  • Roche Holding AG (Switzerland)
  • Bio-Rad Laboratories (US)
  • Eurofins Scientific (Luxembourg)
  • Genomic Health (US)
  • Myriad Genetics (US)
  • Foundation Medicine (US)
  • GE Healthcare (US)
  • Genewiz (US)
  • Luminex Corporation (US)
  • NanoString Technologies (US)
  • ArcherDX (US)
  • F. Hoffmann-La Roche Ltd (Switzerland)

Digital Genome Key Market Trends

  • The increasing adoption of next-generation sequencing (NGS) technologies is a key market trend. NGS technologies are a new generation of sequencing technologies that are faster, more accurate, and more affordable than previous sequencing technologies. This has made NGS technologies more accessible to a wider range of users, which is driving the growth of the digital genome market.

Digital Genome Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our Global Digital Genome market analysis, the increasing adoption of digital genome technology in research and clinical applications. Digital genome refers to the use of computational tools and techniques to analyse and interpret genomic data, enabling researchers and healthcare professionals to gain a deeper understanding of genetic variations, disease mechanisms, and personalised treatment approaches. The market is witnessing a surge in demand as digital genome technology revolutionises genomics research and transforms the healthcare landscape. One of the key drivers identified in the report is the growing prevalence of genetic diseases and the need for effective diagnostic and therapeutic solutions. The ability of digital genome technology to facilitate precise and comprehensive genetic analysis contributes to the development of targeted therapies and personalised treatment plans. This is particularly crucial in the field of oncology, where understanding the genetic makeup of tumours can guide treatment decisions and improve patient outcomes. Another significant driver is the increasing focus on precision medicine and its integration into healthcare systems. Precision medicine aims to deliver tailored healthcare solutions based on an individual's genetic profile. Digital genome technology plays a pivotal role in the implementation of precision medicine by providing tools for genomic data analysis, interpretation, and clinical decision support.

Report Metric Details
Market size value in 2022 USD 22.44 billion
Market size value in 2031 USD 151.4 billion
Growth Rate 18.5%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • Sequencing and Analyzer Instruments and Data Analysis and Management Tools.
  • Application
    • Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research and Other Applications.
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Thermo Fisher Scientific (US)
  • Pacific Biosciences (US)
  • Oxford Nanopore Technologies (UK)
  • BGI Genomics (China)
  • PerkinElmer (US)
  • Qiagen (Netherlands)
  • Roche Holding AG (Switzerland)
  • Bio-Rad Laboratories (US)
  • Eurofins Scientific (Luxembourg)
  • Genomic Health (US)
  • Myriad Genetics (US)
  • Foundation Medicine (US)
  • GE Healthcare (US)
  • Genewiz (US)
  • Luminex Corporation (US)
  • NanoString Technologies (US)
  • ArcherDX (US)
  • F. Hoffmann-La Roche Ltd (Switzerland)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Digital Genome Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Digital Genome Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Digital Genome Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Digital Genome Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Digital Genome Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Digital Genome Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Digital Genome Market size was valued at USD 22.44 billion in 2022 and is poised to grow from USD 26.59 billion in 2023 to USD 151.4 billion by 2031, growing at a CAGR of 18.5% in the forecast period (2024-2031).

The global digital genome market is characterised by intense competition among various players operating in this rapidly evolving sector. The market is witnessing significant growth, driven by advancements in genomic research, increasing adoption of precision medicine, and the growing need for personalised healthcare solutions. The competitive landscape of the market is shaped by factors such as technological innovations, strategic collaborations, research and development activities, and market expansion initiatives. 'Illumina (US)', 'Thermo Fisher Scientific (US)', 'Pacific Biosciences (US)', 'Oxford Nanopore Technologies (UK)', 'BGI Genomics (China)', 'PerkinElmer (US)', 'Qiagen (Netherlands)', 'Roche Holding AG (Switzerland)', 'Agilent Technologies (US)', 'Bio-Rad Laboratories (US)', 'Eurofins Scientific (Luxembourg)', 'Genomic Health (US)', 'Myriad Genetics (US)', 'Foundation Medicine (US)', 'GE Healthcare (US)', 'Genewiz (US)', 'Luminex Corporation (US)', 'NanoString Technologies (US)', 'ArcherDX (US)', 'F. Hoffmann-La Roche Ltd (Switzerland)'

The global prevalence of genetic disorders is increasing, necessitating effective solutions for accurate diagnosis and early intervention. Digital genome technologies have emerged as valuable tools for precise genetic testing, screening, and diagnosis, enabling early detection, prevention, and treatment of genetic disorders.

The increasing adoption of next-generation sequencing (NGS) technologies is a key market trend. NGS technologies are a new generation of sequencing technologies that are faster, more accurate, and more affordable than previous sequencing technologies. This has made NGS technologies more accessible to a wider range of users, which is driving the growth of the digital genome market.

North America emerges as the most dominant market for digital genome technologies. The dominance of this region can be attributed to several factors, including the presence of key market players, well-established healthcare infrastructure, and significant investments in genomics research. The US, in particular, is a major contributor to the North American market, with a high adoption rate of genomic technologies and strong government support in the form of funding and research initiatives.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Report ID: SQMIG35H2104

$5,300
BUY NOW GET FREE SAMPLE